Study of the Effects of Probiotics Upon Infectious Episodes in Subject Aged More Than 60, During Winter.
Effects of Daily Consumption of a Probiotic on the Evolution of Infectious Episodes (ENT, Gastro-intestinal and Pulmonary), in Subject Aged 60 Years or Over, During Winter.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Nantes, France
- Biofortis
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subjects who accept not to alter their food habits
Exclusion Criteria:
- Food allergy
- Regular consumption of probiotics
- Diabetes
- Respiratory deficiency
- Cardiac deficiency
- Cancer or chronicle disease not stabilized
- Splenectomy, sickle-cell anemia
- Immuno depression or immunodeficiency acquired or congenital
- Immuno depressor or corticoid treatments
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: 2
Subject with active product, not vaccinated against influenza.
|
1 pill per day for 12 weeks
|
|
Placebo Comparator: 3
Subject with placebo, vaccinated against influenza.
|
1 pill per day for 12 weeks
|
|
Placebo Comparator: 4
Subject with placebo, not vaccinated against influenza.
|
1 pill per day for 12 weeks
|
|
Experimental: 1
Subject with active product, vaccinated against influenza
|
1 pill per day for 12 weeks
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of infectious episodes
Time Frame: During the study
|
During the study
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Jean Marc Cazaubiel, Dr, Biofortis
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 10308
- 2008-A01187-48
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.